|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
Human influenza hemagglutinin (HA) is a surface glycoprotein required for the infectivity of the human virus. The HA tag is derived from the HA-molecule corresponding to amino acids 98-106 has been extensively used as a general epitope tag in expression vectors. Many recombinant proteins have been engineered to express the HA tag, which does not appear to interfere with the bioactivity or the biodistribution of the recombinant protein. This tag facilitates the detection, isolation, and purification of the proteins.
The actual HA tag is as follows: 5' TAC CCA TAC GAT GTT CCA GAT TAC GCT 3' or 5' TAT CCA TAT GAT GTT CCA GAT TAT GCT 3' The amino acid sequence is: YPYDVPDYA.
|Human FOLH1 ORF mammalian expression plasmid, C-GFPSpark tag||HG15877-ACG|
|Human FOLH1 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||HG15877-ACR|
|Human FOLH1 ORF mammalian expression plasmid, C-Flag tag||HG15877-CF|
|Human FOLH1 ORF mammalian expression plasmid, C-His tag||HG15877-CH|
|Human FOLH1 ORF mammalian expression plasmid, C-Myc tag||HG15877-CM|
|Human FOLH1 ORF mammalian expression plasmid, C-HA tag||HG15877-CY|
|Human FOLH1 Gene cDNA clone plasmid||HG15877-G|
|Human FOLH1 ORF mammalian expression plasmid, N-Flag tag||HG15877-NF|
|Human FOLH1 ORF mammalian expression plasmid, N-His tag||HG15877-NH|
|Human FOLH1 ORF mammalian expression plasmid, N-Myc tag||HG15877-NM|
|Human FOLH1 ORF mammalian expression plasmid, N-HA tag||HG15877-NY|
|Human FOLH1 natural ORF mammalian expression plasmid||HG15877-UT|
|Learn more about expression Vectors|
Glutamate carboxypeptidase 2, also known as Glutamate carboxypeptidase II, Membrane glutamate carboxypeptidase, Prostate-specific membrane antigen, GCPII, PSMA, FOLH1, and NAALAD1, is a single-pass type I I membrane protein which belongs to the peptidase M28 family and M28B subfamily. FOLH1 is highly expressed in prostate epithelium. It is detected in urinary bladder, kidney, testis, ovary, fallopian tube, breast, adrenal gland, liver, esophagus, stomach, small intestine, colon, brain (at protein level), and the capillary endothelium of a variety of tumors. FOLH1 has both folate hydrolase and N-acetylated alpha linked acidic dipeptidase (NAALADase) activity. It has a preference for tri-alpha-glutamate peptides. Genetic variation in FOLH1 may be associated with low folate levels and consequent hyperhomocysteinemia. This condition can result in increased risk of cardiovascular disease, neural tube defects, and cognitive deficits. FOLH1 also shows a promising role in directed imaging and therapy of recurrent or metastatic disease.